Relx N.V. (NYSE:RENX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Friday.

According to Zacks, “RELX NV provides professional information solutions primarily in North America and Europe. The company’s operating segments consists of Scientific, Technical & Medical; Risk & Business Information; Legal, and Exhibitions. Scientific, Technical & Medical segment provides information and tools to help customers improve scientific and healthcare outcomes. Risk & Business Information segment provides data and analytics which enable customers to evaluate and manage risk. Legal segment provides legal, regulatory, news, business information and analysis to legal, corporate, Government and academic customers. Exhibitions segment, through the subsidiary Reed Exhibitions, organizes market events relevant to industry needs. RELX NV, formerly known as Reed Elsevier NV, is based in Amsterdam, the Netherlands. “

Separately, BidaskClub cut Relx N.V. from a “buy” rating to a “hold” rating in a research report on Wednesday, July 5th.

Shares of Relx N.V. (NYSE:RENX) traded up 0.14% during trading on Friday, hitting $21.33. 35,497 shares of the stock traded hands. Relx N.V. has a 52 week low of $14.92 and a 52 week high of $21.37. The company has a market cap of $42.98 billion, a price-to-earnings ratio of 26.33 and a beta of 0.86. The firm’s 50-day moving average price is $20.93 and its 200-day moving average price is $19.83.

COPYRIGHT VIOLATION NOTICE: “Zacks Investment Research Lowers Relx N.V. (RENX) to Hold” was published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.americanbankingnews.com/2017/09/09/zacks-investment-research-lowers-relx-n-v-renx-to-hold.html.

A number of institutional investors have recently added to or reduced their stakes in RENX. JPMorgan Chase & Co. raised its stake in Relx N.V. by 1,953.0% during the first quarter. JPMorgan Chase & Co. now owns 174,445 shares of the technology company’s stock worth $3,237,000 after acquiring an additional 165,948 shares in the last quarter. Parametric Portfolio Associates LLC raised its stake in Relx N.V. by 15.0% during the second quarter. Parametric Portfolio Associates LLC now owns 810,884 shares of the technology company’s stock worth $16,769,000 after acquiring an additional 105,521 shares in the last quarter. Morgan Stanley raised its stake in Relx N.V. by 83.9% during the first quarter. Morgan Stanley now owns 176,616 shares of the technology company’s stock worth $3,278,000 after acquiring an additional 80,567 shares in the last quarter. Karp Capital Management Corp acquired a new position in Relx N.V. during the first quarter worth $1,228,000. Finally, Bank of America Corp DE raised its stake in Relx N.V. by 6.6% during the first quarter. Bank of America Corp DE now owns 1,040,732 shares of the technology company’s stock worth $19,316,000 after acquiring an additional 64,722 shares in the last quarter. Hedge funds and other institutional investors own 1.07% of the company’s stock.

Relx N.V. Company Profile

RELX NV is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions.

Get a free copy of the Zacks research report on Relx N.V. (RENX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Relx N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx N.V. and related companies with MarketBeat.com's FREE daily email newsletter.